Targeted Alpha Therapeutics: Audience

Fusion Pharma specializes in developing next-generation radiopharmaceuticals that utilize targeted alpha therapeutics to treat cancer. Their innovative approach focuses on improving the safety and efficacy of cancer treatments through precision medicine.